logo-loader

Market report: FTSE in negative territory after news Trump tested positive for COVID-19

Published: 05:23 02 Oct 2020 EDT

FTSE 100 opened lower after investors were spooked by news Donald Trump had tested positive for COVID-19 and was in a quarantine period. London’s blue-chip index shed 44 points to 5,835 in early trading.

TUI (LON:TUI) has confirmed it is mulling a share issue but said it would be “significantly lower” than the €1-1.5bn mentioned in reports overnight. The travel company’s business has been battered by the pandemic.

AstraZeneca’s (LON:AZN) new coronavirus vaccine is facing a wider US inquiry into its safety, according to Reuters.  A US study has been on halt since September after a trialist in Britain fell ill.

Ryanair (LON:RYA) said traffic in September dropped by 64% to 5.1mln passengers compared to this time a year ago. COVID-19 restrictions were blamed by the airline.  

Among the small caps, Scancell Holdings (LON:SCLP) has signed up Cobra Biologics to manufacture its COVID-19 vaccine candidate. The biotech said it was a critical step towards clinical trials.

OptiBiotix Health (LON:OPI) revealed a candidate containing one of its probiotics will begin clinical trials in the US. The drug is for irritable bowel syndrome and has been developed by Seed Health.

One Media iP (LON:OMIP) has completed the acquisition of the music catalogue of US composer Philip Wesley. The music rights owner paid the final instalment of US$100,000 after agreeing the deal last year.

ARway.ai announces multiple new SaaS developer contracts in both the United...

ARway.ai (CSE:ARWY, OTCQB:ARWYF) Chief Executive Officer Evan Gappelberg joined Steve Darling from Proactive to announce multiple new SaaS developer sign-ups for its augmented reality experience platform, focusing on AR indoor navigation. These partnerships represent significant milestones in...

1 hour, 54 minutes ago